Dr. Ryan Gamble, MD
Dermatology (Dermatology Physician)
1390 S Potomac St, Suite 124
Aurora, CO 80012
Who else practices at this address →
Arapahoe County includes primary care (8% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Colorado School of Medicine, Denver (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 774
Licensed in Colorado since 2015, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: University of Colorado School of Medicine, Denver
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
CO license DR.0054904 (first issued 2015; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Advanced Dermatology Skin Cancer and Laser Surgery Center P.c. (15 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 774
- Services billed
- 2,735
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 764 | 560 |
| Destruction of precancer skin growth, 2-14 growths | 473 | 114 |
| Destruction of skin growth, 1-14 growths | 305 | 268 |
| Biopsy of related skin growth, first growth | 265 | 227 |
| Destruction of precancer skin growth, 15 or more growths | 264 | 189 |
| Destruction of precancer skin growth, 1 growth | 158 | 145 |
| Biopsy of related skin growth, each additional growth | 129 | 73 |
| New patient office or other outpatient visit, 30-44 minutes | 125 | 125 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | 24 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 45 | 38 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 129 payments worth $2,434 in total to this clinician.
| Food and Beverage | $2,419 |
|---|---|
| Education | $15.27 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Mar 17, 2025 | Education CIBINQO · Inflammation & Immunology · in-kind | $15.27 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.